Héctor M. García‐García

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet · 2009 · 816 citations

Percutaneous Coronary Intervention, Cardiovascular Translational Research, Cardiovascular Disease +10

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

Vasim Farooq, David van Klaveren, Ewout W. Steyerberg et al. · The Lancet · 2013 · 813 citations

Cardiac Surgery, Percutaneous Coronary Intervention, Cardiovascular Disease +11

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

John A. Ormiston, Patrick W. Serruys, Evelyn Regar et al. · The Lancet · 2008 · 714 citations

Percutaneous Coronary Intervention, Prospective Open-label Trial, Cardiovascular Disease +6

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 556 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Endovascular Technique +11

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek et al. · Journal of the American College of Cardiology · 2011 · 525 citations

Tissue Engineering, Percutaneous Coronary Intervention, Engineering +11